close
read more
Our company
Governance
Global presence
Key figures
Story
Vocation and values
Culture
Financial Results
Servier Institute
Our Products
Servier medicines
Generic drugs
e-Health solutions
Fight against counterfeiting
Areas of expertise
Research & Development
Research Axes
Development portfolio
Clinical trials
Paediatric expertise
Regulatory affairs
Pharmacovigilance
Medical promotion
Industry
Industrial quality
Production
Supply Chain
CDMO Services
Medical Affairs
Business development & licensing
Cross-functional activities
Our commitments
Patient In
Ethics
Compliance policy
CSR approach
Servier endowment fund
Newsroom
News
Press release
Insight
Corporate documents
Medical publishing
FR
NEWS
ROOM
News
Press release
Insight
Corporate documents
Medical publishing
WeHealth Digital Medicine and French start-up Lucine sign partnership to develop digital therapeutics
17 / 07 / 2019
Press release
Servier Australia & BioCurate strike an agreement to collaborate and accelerate discoveries of new therapeutics and drugs
16 / 07 / 2019
Press release
Servier Breaks Ground of Servier Paris-Saclay Research Institute
19 / 06 / 2019
Press release
Servier and MBC BioLabs Announce Winner of the 2019 Servier Golden Ticket
12 / 06 / 2019
Press release
Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
11 / 06 / 2019
Press release
Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology
06 / 06 / 2019
Press release
Servier Showcases Robust Presence at ASCO 2019
29 / 05 / 2019
Press release
Servier Cuts Ribbon on New Boston Headquarters
10 / 05 / 2019
Press release
Hypertension: a new campaign Because I Say So for Servier
29 / 04 / 2019
Press release
Servier China: Committed to Care for 40 Years
16 / 04 / 2019
Press release
Servier joins Access Accelerated to fight against non-communicable diseases
04 / 04 / 2019
Press release
Servier collaborates with Harvard researchers to fight metabolic diseases
21 / 03 / 2019
Press release
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
No
Read more